GSK’s Rappuoli and colleagues propose model for sustainable vaccine development

A perspective article in Science Translational Medicine co-authored by GlaxoSmithKline’s Rino Rappuoli argues that to make global vaccine development sustainable, pharmas should contribute early in the process and

Read the full 289 word article

User Sign In